REFERENCES
- Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to in-fant. New Engl J Med. 1996;335:1621–1629.
- Mofenson LM, Lambert JS, Stiehm R, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New Engl J Med. 1999;341:385–393.
- Blattner W, Cooper E, Charurat M, et al. Effectiveness of potent anti-retroviral therapies on reducing perinatal trans-mission of HIV-1. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract LbOr4.
- CDC. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR. 1994;43:285–287.
- Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl J Med. 1994;331:1173–1180.
- CDC. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission. MMWR. 1998;47:151–154.
- Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial. Lancet. 1999;353:773–780.
- Lallemant M, Jourdain G, LeCoeur S, et al. Perinatal HIV prevention trial (PHPT), Thailand: Simplified and shortened zidovudine prophylaxis regimen as efficacious as PACTG076. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract LbOr3.
- Wade NA, Birkhead GS, Warren B, et al. Abbreviated regi-mens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. New Engl J Med. 1998;339:1409–1414.
- Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial. Lan-cet. 1999;353:781–785.
- Wiktor SZ, Leroy V, Ekpini ER. 24-month efficacy of short-course zidovudine for the prevention of mother-to-child HIV-1 transmission in a breast feeding population: A pooled analysis of two randomized trials in West Africa. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract TuOrB354.
- Dabis F, Msellati P, Meda N, et al. 6-month efficacy, toler-ance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote D'Ivoire and Burkina Faso: A double-blind, placebo-controlled multicenter trial. Lancet. 1999;353:786–792.
- Ditrame ANRS 049 Study Group. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. Lancet. 1999;354:2050–2051.
- Saba J. Interim analysis of early efficacy of three short ZDV/3TC combination regimens to prevent mother-child transmission of HIV-1: The PETRA Trial. Sixth Conference on Retroviruses and Opportunistic Infections; January 31 - February 4, 1999; Chicago. Abstract S7.
- Gray G. The PETRA Study: Early and late efficacy of three short ZDV/3TC combination regimens to prevent MTCT of HIV-1. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract LbOr5.
- Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802.
- Owor M, Deseyve M, Duefield, et al. The one year safety and efficacy data of the HIVNET 012 trial. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract LbOr1.
- Becker-Pergola G, Guay L, Mmiro F, et al. Selection of the K103N nevirapine resistance mutation in Ugandan women receiving NVP prophylaxis to prevent HIV-1 vertical trans-mission (HIVNET-006). Seventh Conference on Retroviruses and Opportunistic Infections; January 30 - February 2,2000; San Francisco. Abstract 658.
- Jackson JB, Mracna M, Guay L, et al. Selection of nevirapine resistance mutations in Ugandan women and infants receiving NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET 012). XIII International AIDS Confer-ence; July 9–14, 2000; Durban. Abstract LbOr13.
- Moodley D. The SAINT trial: Nevirapine (NVP) versus zidovudine (ZDV) + lamivudine (3TC) in prevention of peripartum HIV transmission. XIII International AIDS Con-ference; July 9–14, 2000; Durban. Abstract LbOr1.
- Gray G, McIntyre J, Jivkov B, et al. Preliminary efficacy, safety, tolerability, and pharmacokinetics of short course regimens of nucleoside analogs for the prevention of mother-to-child transmission of HIV. XIII International AIDS Conference; July 9–14, 2000; Durban. Abstract TuOrB355.